Title : Is there a need for "triple therapy"? Role of anticoagulation with dual antiplatelet therapy in acute coronary syndromes (ATLAS Study & TRAP Study).

Pub. Date : 2013 Oct

PMID : 24022544






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dual pathway regimens that combine antiplatelets (aspirin and a thienopyridine), along with an anticoagulant such as rivaroxaban may prove to be a therapeutic option in patients with ACS. Rivaroxaban 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens